Yang Mengdie, Sun Bo, Chang Cai, Chen Yaling, Zhi Wenxiang, Zhang Haixian
Department of Ultrasound, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Quant Imaging Med Surg. 2025 May 1;15(5):4470-4477. doi: 10.21037/qims-24-924. Epub 2025 Apr 28.
Due to their heterogeneous nature, the diagnosis and treatment of intraductal lesions are controversial. It is not yet clear whether biopsy or open surgery should be recommended for all women with intraductal lesions. We aimed to identify the risk factors of intraductal lesions, which are often malignant.
We retrospectively investigated the relationship between patient age, nipple discharge, ultrasound (US) findings, and the final pathology outcomes of intraductal lesions to identify the variables associated with malignancy.
A total of 1,058 patients with 1,069 pathologically proven intraductal lesions were included in this study. The age of the patients ranged from 18 to 86 years (mean age: 46.8±11.6 years). The pathologic findings of the 1,069 lesions revealed 288 cases of duct ectasia, 642 cases of intraductal papilloma (IP), 45 cases of IP with ductal carcinoma in situ (DCIS), and 94 cases of solid papillary carcinoma (SPC). An alluvial diagram of patient age, nipple discharge, US findings, and pathologic results showed that the relationship among these variables is complicated and intertwined. In general terms, the lesions were more likely to be malignant in older patients and those with bloody nipple discharge. The US subtypes I-III had similar rates of malignancy; however the rate of malignancy of the US subtype V differed. Bloody nipple discharge and an age ≥60 years were identified as independent predictors of malignancy.
Our findings may guide doctors in risk stratification and in making decisions for patients with intraductal lesions.
由于导管内病变具有异质性,其诊断和治疗存在争议。对于所有患有导管内病变的女性,是否应推荐活检或开放手术尚不清楚。我们旨在确定导管内病变(通常为恶性)的危险因素。
我们回顾性研究了患者年龄、乳头溢液、超声(US)检查结果与导管内病变最终病理结果之间的关系,以确定与恶性肿瘤相关的变量。
本研究共纳入1058例患者,其1069处导管内病变经病理证实。患者年龄在18至86岁之间(平均年龄:46.8±11.6岁)。1069处病变的病理结果显示,288例为导管扩张,642例为导管内乳头状瘤(IP),45例为伴有导管原位癌(DCIS)的IP,94例为实性乳头状癌(SPC)。患者年龄、乳头溢液、US检查结果和病理结果的冲积图显示,这些变量之间的关系复杂且相互交织。一般来说,老年患者和乳头血性溢液患者的病变更有可能是恶性的。US I - III型的恶性率相似;然而,US V型的恶性率有所不同。乳头血性溢液和年龄≥60岁被确定为恶性肿瘤的独立预测因素。
我们的研究结果可能会指导医生对导管内病变患者进行风险分层并做出决策。